BCC Research Shows Better Survival Rates for Its Thoracic Oncology Patients

Baptist Cancer Center research was published in the February 2024 Journal of Thoracic Oncology Clinical and Research Reports (JTO-CRR) showing patients who received lung cancer care from Baptist Cancer Center’s structured Thoracic Oncology Program had three times better survival than patients whose care was delivered outside the program.

Program-Based Lung Cancer Care: A Prospective Observational Tumor Registry Linkage Study” (10.1016/j.jtocrr.2023.100629) compared patients who were treated through three specific programs to those who had non-programmatic care. The programs included lung cancer screening, guideline-concordant management of incidentally detected lung nodules (based on the Fleischner Society’s guidelines) and a structured multidisciplinary decision-making care pathway.

The results showed there is a large survival benefit for patients going through the dedicated lung cancer care program at Baptist Cancer Center. For more details on the survival benefit, refer to the graph below.

“As an institution, we want to raise awareness to increase access to these programs and help provide better care for our patients,” said Chief Scientist at Baptist Memorial Health Care and Director of the Multidisciplinary Thoracic Oncology Program and the Thoracic Oncology Research Group at Baptist Cancer Center Dr. Raymond Osarogiagbon. “We want to get the word out to our patients, caregivers, partner clinicians and the Mid-South regional community that superior lung cancer care and outcomes are available right here at home. People don’t have to travel far away from home to receive world-class, life-saving lung cancer care.”